{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:36Z","timestamp":1790352516750,"version":"4.1.0"},"reference-count":44,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Few studies have evaluated the association between DNA methylation in white blood cells (WBC) and the risk of breast cancer. The evaluation of WBC DNA methylation as a biomarker of cancer risk is of particular importance as peripheral blood is often available in prospective cohorts and easier to obtain than tumor or normal tissues. Here, we used prediagnostic blood samples from three studies to analyze WBC DNA methylation of two ATM intragenic loci (ATMmvp2a and ATMmvp2b) and genome-wide DNA methylation in long interspersed nuclear element-1 (LINE1) repetitive elements. Samples were from a case\u2013control study derived from a cohort of high-risk breast cancer families (KConFab) and nested case\u2013control studies in two prospective cohorts: Breakthrough Generations Study (BGS) and European Prospective Investigation into Cancer and Nutrition (EPIC). Bisulfite pyrosequencing was used to quantify methylation from 640 incident cases of invasive breast cancer and 741 controls. Quintile analyses for ATMmvp2a showed an increased risk of breast cancer limited to women in the highest quintile [OR, 1.89; 95% confidence interval (CI), 1.36\u20132.64; P = 1.64 \u00d7 10\u22124]. We found no significant differences in estimates across studies or in analyses stratified by family history or menopausal status. However, a more consistent association was observed in younger than in older women and individually significant in KConFab and BGS, but not EPIC. We observed no differences in LINE1 or ATMmvp2b methylation between cases and controls. Together, our findings indicate that WBC DNA methylation levels at ATM could be a marker of breast cancer risk and further support the pursuit of epigenome-wide association studies of peripheral blood DNA methylation. Cancer Res; 72(9); 2304\u201313. \u00a92012 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-11-3157","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T22:49:35Z","timestamp":1330469375000},"page":"2304-2313","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk"],"prefix":"10.1158","volume":"72","author":[{"given":"Kevin","family":"Brennan","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Garcia-Closas","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"},{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Orr","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jones","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Ashworth","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Thorne","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Riboli","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vineis","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"},{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Dorronsoro","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Clavel-Chapelon","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Panico","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Charlotte","family":"Onland-Moret","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Trichopoulos","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"},{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brown","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"},{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Epigenetics Unit, Department of Surgery and Cancer, 2MRC-HPA Centre, 3School of Public Health, Imperial College; 4Breakthrough Breast Cancer Research Centre, 5Section of Medicine, Institute for Cancer Research, London; 6Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 7Peter MacCallum Cancer Center, Melbourne, Victoria, Australia; 8HuGeF Foundation, Torino, Italy; 9Public Health Division of Gipuzkoa, IIS Institute BioDonostia, Basque Health Department; CIBER Epidemiolog\u00eda y Salud P\u00fablica, CIBERESP, Gipuzkoa, Spain; 10INSERM, Centre for Research in Epidemiology and Population Health, Institut Gustave Roussy, University Paris-Sud, Paris, France; 11Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy; 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; 14Hellenic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2012,4,30]]},"reference":[{"key":"2022061703541903600_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"2022061703541903600_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tig.2004.06.009","article-title":"An integrated epigenetic and genetic approach to common human disease","volume":"20","author":"Bjornsson","year":"2004","journal-title":"Trends Genet"},{"key":"2022061703541903600_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1101\/gr.103606.109","article-title":"Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer","volume":"20","author":"Teschendorff","year":"2010","journal-title":"Genome Res"},{"key":"2022061703541903600_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1101\/gr.103101.109","article-title":"Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains","volume":"20","author":"Rakyan","year":"2010","journal-title":"Genome Res"},{"key":"2022061703541903600_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2003.tb05971.x","article-title":"Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers","volume":"983","author":"Li","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"2022061703541903600_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mrfmmm.2003.12.016","article-title":"Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation","volume":"548","author":"Kovalchuk","year":"2004","journal-title":"Mutat Res"},{"key":"2022061703541903600_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/09553001003734592","article-title":"Low-dose radiation-induced responses: focusing on epigenetic regulation","volume":"86","author":"Ma","year":"2010","journal-title":"Int J Radiat Biol"},{"key":"2022061703541903600_bib8","doi-asserted-by":"crossref","first-page":"e1001043","DOI":"10.1371\/journal.pgen.1001043","article-title":"Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake","volume":"6","author":"Christensen","year":"2010","journal-title":"PLoS Genet"},{"key":"2022061703541903600_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4161\/epi.6.2.13573","article-title":"DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study","volume":"6","author":"Vineis","year":"2011","journal-title":"Epigenetics"},{"key":"2022061703541903600_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ajhg.2011.03.003","article-title":"Tobacco-smoking-related differential DNA methylation: 27K discovery and replication","volume":"88","author":"Breitling","year":"2011","journal-title":"Am J Hum Genet"},{"key":"2022061703541903600_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/rccm.200807-1097OC","article-title":"Rapid DNA methylation changes after exposure to traffic particles","volume":"179","author":"Baccarelli","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2022061703541903600_bib12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4161\/epi.5.7.12960","article-title":"Allele-specific methylation in the human genome: implications for genetic studies of complex disease","volume":"5","author":"Meaburn","year":"2010","journal-title":"Epigenetics"},{"key":"2022061703541903600_bib13","doi-asserted-by":"crossref","first-page":"49ra67","DOI":"10.1126\/scitranslmed.3001262","article-title":"Personalized epigenomic signatures that are stable over time and covary with body mass index","volume":"2","author":"Feinberg","year":"2010","journal-title":"Sci Transl Med"},{"key":"2022061703541903600_bib14","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/hmg\/ddp033","article-title":"Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients","volume":"18","author":"Flanagan","year":"2009","journal-title":"Hum Mol Genet"},{"key":"2022061703541903600_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1200\/JCO.2010.31.3577","article-title":"DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer","volume":"29","author":"Marsit","year":"2011","journal-title":"J Clin Oncol"},{"key":"2022061703541903600_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1470-2045(08)70038-X","article-title":"Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study","volume":"9","author":"Moore","year":"2008","journal-title":"Lancet Oncol"},{"key":"2022061703541903600_bib17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/ijc.26098","article-title":"LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese","volume":"130","author":"Cash","year":"2012","journal-title":"Int J Cancer"},{"key":"2022061703541903600_bib18","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1158\/1078-0432.CCR-09-2983","article-title":"Implications of LINE1 methylation for bladder cancer risk in women","volume":"16","author":"Wilhelm","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2022061703541903600_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/1055-9965.EPI-06-0636","article-title":"Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma","volume":"16","author":"Hsiung","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022061703541903600_bib20","first-page":"2489","article-title":"Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients","volume":"30","author":"Cho","year":"2010","journal-title":"Anticancer Res"},{"key":"2022061703541903600_bib21","first-page":"6442","article-title":"Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2","volume":"62","author":"Cui","year":"2002","journal-title":"Cancer Res"},{"key":"2022061703541903600_bib22","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1126\/science.1080902","article-title":"Loss of IGF2 imprinting: a potential marker of colorectal cancer risk","volume":"299","author":"Cui","year":"2003","journal-title":"Science"},{"key":"2022061703541903600_bib23","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1053\/j.gastro.2003.12.051","article-title":"Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition","volume":"126","author":"Cruz-Correa","year":"2004","journal-title":"Gastroenterology"},{"key":"2022061703541903600_bib24","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1053\/j.gastro.2004.02.026","article-title":"IGF2 loss of imprinting: a potential heritable risk factor for colorectal cancer","volume":"126","author":"Jirtle","year":"2004","journal-title":"Gastroenterology"},{"key":"2022061703541903600_bib25","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1093\/hmg\/ddn163","article-title":"Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer","volume":"17","author":"Ito","year":"2008","journal-title":"Hum Mol Genet"},{"key":"2022061703541903600_bib26","doi-asserted-by":"crossref","first-page":"e2656","DOI":"10.1371\/journal.pone.0002656","article-title":"Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study","volume":"3","author":"Widschwendter","year":"2008","journal-title":"PLoS One"},{"key":"2022061703541903600_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-010-1188-1","article-title":"BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation","volume":"129","author":"Iwamoto","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"2022061703541903600_bib28","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1858","article-title":"BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype","volume":"10","author":"Snell","year":"2008","journal-title":"Breast Cancer Res"},{"key":"2022061703541903600_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/1940-6207.CAPR-10-0212","article-title":"Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer","volume":"4","author":"Wong","year":"2010","journal-title":"Cancer Prev Res(Phila)"},{"key":"2022061703541903600_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1741-7015-8-87","article-title":"Obesity related methylation changes in DNA of peripheral blood leukocytes","volume":"8","author":"Wang","year":"2010","journal-title":"BMC Med"},{"key":"2022061703541903600_bib31","doi-asserted-by":"crossref","first-page":"e18223","DOI":"10.1371\/journal.pone.0018223","article-title":"Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls","volume":"6","author":"Pedersen","year":"2011","journal-title":"PLoS One"},{"key":"2022061703541903600_bib32","doi-asserted-by":"crossref","first-page":"e8274","DOI":"10.1371\/journal.pone.0008274","article-title":"An epigenetic signature in peripheral blood predicts active ovarian cancer","volume":"4","author":"Teschendorff","year":"2009","journal-title":"PLoS One"},{"key":"2022061703541903600_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.semcancer.2004.06.005","article-title":"The epigenetics of cancer etiology","volume":"14","author":"Feinberg","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"2022061703541903600_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ng.298","article-title":"The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores","volume":"41","author":"Irizarry","year":"2009","journal-title":"Nat Genet"},{"key":"2022061703541903600_bib35","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1377","article-title":"Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource","volume":"8","author":"Mann","year":"2006","journal-title":"Breast Cancer Res"},{"key":"2022061703541903600_bib36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/bjc.2011.337","article-title":"The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology","volume":"105","author":"Swerdlow","year":"2011","journal-title":"Br J Cancer"},{"key":"2022061703541903600_bib37","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.S6","article-title":"The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition","volume":"26","author":"Riboli","year":"1997","journal-title":"Int J Epidemiol"},{"key":"2022061703541903600_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"2022061703541903600_bib39","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/carcin\/bgp143","article-title":"Association between global DNA hypomethylation in leukocytes and risk of breast cancer","volume":"30","author":"Choi","year":"2009","journal-title":"Carcinogenesis"},{"key":"2022061703541903600_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ajhg.2010.02.008","article-title":"DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status","volume":"86","author":"Flanagan","year":"2010","journal-title":"Am J Hum Genet"},{"key":"2022061703541903600_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4161\/epi.6.1.13393","article-title":"Global DNA methylation levels in girls with and without a family history of breast cancer","volume":"6","author":"Wu","year":"2011","journal-title":"Epigenetics"},{"key":"2022061703541903600_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/bjc.2011.550","article-title":"Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research","volume":"106","author":"Shenker","year":"2012","journal-title":"Br J Cancer"},{"key":"2022061703541903600_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1755-8794-4-61","article-title":"Integrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumors","volume":"4","author":"Labreche","year":"2011","journal-title":"BMC Med Genomics"},{"key":"2022061703541903600_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrg3000","article-title":"Epigenome-wide association studies for common human diseases","volume":"12","author":"Rakyan","year":"2011","journal-title":"Nat Rev Genet"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/72\/9\/2304\/2686094\/2304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/72\/9\/2304\/2686094\/2304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:42:52Z","timestamp":1655458972000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/72\/9\/2304\/584234\/Intragenic-ATM-Methylation-in-Peripheral-Blood-DNA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,30]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2012,4,30]]},"published-print":{"date-parts":[[2012,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-11-3157","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6504248.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6504248","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395248","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395248.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395242","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22395242.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,30]]}}}